Bettina Schelbert Joins Swizzard's Board of Directors as Vice-President

We are pleased to announce that Bettina Schelbert, Commercial Director at Swizzard Pharma AG, has been appointed Vice-President of the Board of Directors, effective September 1, 2026.

Since joining Swizzard, Bettina has been instrumental in the company's growth, combining strong commercial expertise with an entrepreneurial mindset and a deep understanding of our clients' needs. In her new role, she will further strengthen our Board by bringing valuable operational insight and hands-on industry experience to our strategic decision-making.

Commenting on her appointment, Bettina said: "I have had the privilege of growing together with Swizzard over the past years, and I am grateful for this opportunity. Joining the Board is both an honor and a responsibility. I look forward to contributing from a new perspective while remaining closely connected to our clients, projects, and outstanding team."

I am personally delighted to welcome Bettina to the Board and look forward to working even more closely together as we continue to shape the future of Swizzard Pharma AG. 

Please join me in congratulating Bettina on this exciting new chapter and wishing her every success, fulfilment, and joy in her new role.

---

About Swizzard

Swizzard Pharma AG supports biotech and pharma companies in successfully entering and thriving in the Swiss market. Committed to bringing innovation to Switzerland, Swizzard helps clients maximize the value of their medical breakthroughs through expert market entry, preparation, commercialization and access strategies. With deep industry expertise, hands-on experience and an extensive network, Swizzard delivers fast, efficient, and tailored solutions. The company is led by CEO Michael Zürcher, a seasoned life sciences executive with a strong track record in the industry.

Contact us